MeSH term
Frequency | Condition_Probility | Humans | 26 | 0.0 |
Binding Sites | 3 | 0.0 |
*DNA Repair | 10 | 1.0 |
Deoxyribonuclease (Pyrimidine Dimer) | 11 | 47.0 |
Endodeoxyribonucleases/genetics/*metabolism | 2 | 16.0 |
Hela Cells | 4 | 0.0 |
Research Support, Non-U.S. Gov't | 13 | 0.0 |
Amino Acid Sequence | 6 | 0.0 |
Animals | 10 | 0.0 |
Base Pair Mismatch | 4 | 2.0 |
Base Sequence | 7 | 0.0 |
Colonic Neoplasms/genetics | 2 | 3.0 |
Comparative Study | 3 | 0.0 |
Cytosine/*analogs & derivatives/metabolism | 2 | 22.0 |
DNA Damage | 3 | 0.0 |
DNA, Neoplasm/genetics | 2 | 0.0 |
Deamination | 3 | 33.0 |
Mice | 4 | 0.0 |
Models, Genetic | 3 | 0.0 |
Molecular Sequence Data | 10 | 0.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Structure-Activity Relationship | 3 | 0.0 |
Substrate Specificity | 7 | 0.0 |
Transcription, Genetic | 2 | 0.0 |
Transfection | 3 | 0.0 |
COS Cells | 2 | 0.0 |
Dose-Response Relationship, Drug | 4 | 0.0 |
Mutation | 4 | 0.0 |
N-Glycosyl Hydrolases/*chemistry | 2 | 33.0 |
Precipitin Tests | 2 | 0.0 |
Protein Binding | 2 | 0.0 |
Rats | 2 | 0.0 |
*Thymine DNA Glycosylase | 2 | 66.0 |
Trans-Activation (Genetics) | 2 | 0.0 |
Two-Hybrid System Techniques | 2 | 0.0 |
Base Pair Mismatch/*genetics | 2 | 3.0 |
Tumor Cells, Cultured | 5 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 8 | 0.0 |
*DNA Glycosylases | 3 | 4.0 |
Genetic Vectors | 2 | 0.0 |
DNA/metabolism | 2 | 0.0 |
Mutagenesis, Site-Directed | 3 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 2 | 0.0 |
Oxidation-Reduction | 2 | 0.0 |
Thymine/metabolism | 2 | 18.0 |
Uracil/metabolism | 2 | 18.0 |
*Base Pair Mismatch | 2 | 2.0 |
Escherichia coli/enzymology | 2 | 3.0 |
Endodeoxyribonucleases/*genetics | 2 | 10.0 |
Adenosine Triphosphate/metabolism | 2 | 0.0 |
DNA/*genetics | 2 | 0.0 |
Cell Nucleus/metabolism | 2 | 0.0 |
DNA Repair | 4 | 0.0 |
Recombinant Proteins/genetics/metabolism | 3 | 0.0 |
Cell-Free System | 2 | 0.0 |
Uracil/*analogs & derivatives/*metabolism | 2 | 100.0 |
